News

Medscape2h
Catching Resistance Early: Can Switching to Breast Cancer Drug Camizestrant Help?
A ctDNA-guided approach can help identify when patients with HR-positive advanced breast cancer are developing an ESR1 ...
Equities News3d
Michael McTague: Watch out for these killer superbugs that resist today’s antibiotics
These mutated diseases defy the power of antibiotics. Are illnesses really mutating so fast that we can’t stay ahead of them?
MedPage Today on MSN2d
Myeloma Trial Results Spark Talk of 'Potential Cure'
CHICAGO -- A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel (cilta-cel; ...
JD Supra1mon
GSK and Pfizer Stipulate to Dismissal of RSV Vaccines Lawsuit
On April 3, 2025, GlaxoSmithKline (GSK) and Pfizer filed a stipulation to dismiss with prejudice GSK’s litigation in the United States District Court for the District of Delaware. GSK filed suit ...
Berenberg Bank downgrades GlaxoSmithKline (GSK) to a Hold
GlaxoSmithKline (GSK – Research Report) received a Hold rating and a $41.00 price target from Berenberg Bank analyst Kerry Holford today. Confident Investing Starts Here: Easily ...
Reuters2mon
GSK resolves patent lawsuit against Pfizer over RSV vaccines
April 3 (Reuters) - British pharmaceutical giant GlaxoSmithKline (GSK.L), opens new tab and rival Pfizer (PFE.N), opens new tab have agreed to end a lawsuit that alleged Pfizer's respiratory ...